Back to top

Analyst Reiterates Buy on ABSI, Sees Upside Ahead of ABS-201 Readout with ATLAS AI Platform Support and Unchanged $16 Price Target

AbSci, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula Ramakanth from H.C. Wainwright maintained ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Absci Corporation (ABSI)